 Buy trial packs
Hello,
Order was received yesterday, faster than predicted. Excellent again. Thank you very much. I look forward to future orders.
- Claudia G.,
Las Vegas, United States
|

News: Law suits
Category:
Law suits
Region:
India
|
|
INDIAN PATENT LAWS DO NOT ENCOURAGE RESEARCH
Date: 29-Oct-2008
Author: Rama Kant Mishra
THE RECENT statement made by Ranjit Shahani, vice chairman and MD, Novartis India Ltd, to a scientific magazine clearly indicates that Indian patent laws do not encourage world-class research. It is noteworthy that the most important step that India took was to move from a process patent to product patent after 35 long years. But many now questions this to make it world -class, WTO and TRIPS agreement compliant. These are no other than the major MNC in pharmaceutical and drug discovery and research business. Novartis is one of them, which had spat with Indian Patents Office for getting the patent denied for Glivec. The disagreement is over the section 3(d) of Indian Patent laws which states that incremental innovation is not patentable.
|
|
Category:
Law suits
Region:
Kenya
|
|
LAW AGAINST COUNTERFEITS GETS BACKING
Date: 25-Oct-2008
Author: KABURU MUGAMBI
The proposed Anti-Counterfeit Bill, 2008 continues to elicit mixed reactions, with the Kenya Bureau of Standards supporting its enactment.
|
|
Category:
Law suits
Region:
United Kingdom
|
|
PROTESTS FORCE REVIEW OF BAN ON CANCER DRUGS
Date: 30-Aug-2008
Author: Sarah-Kate Templeton
The National Health Service drugs rationing body has been forced to review its policy of banning life-prolonging cancer medicines that are available elsewhere in Europe.
|
|
Category:
Law suits
Region:
Australia
|
|
ACTAVIS RECEIVES APPROVAL OF GENERIC WELLBUTRIN IN U.S.
Date: 18-Aug-2008
Actavis Group today announced that it has received approval from the U.S. Food & Drug Administration to market Bupropion Hydrochloride extended-release tablets (XL) 300mg. Distribution of the product will commence immediately.
|
|
Category:
Law suits
Region:
Ireland
|
|
DORGAN PHARMACY REPORT UNLIKELY TO END CONFLICT
Date: 10-Aug-2008
Author: Samantha McCaughren
The much-anticipated report on pharmacy fees by the independent body headed by Sean Dorgan appears unlikely to resolve the row between the HSE and Irish pharmacies.
|
|
|
Next page >>
|
|


|
|
About us | F.A.Q. | How to Order | Contact us | RX online | Drugs directory
Copyright © 2006 - 2008 DRUGSWWW.com All rights reserved.
|
|